The long term prognostic significance of c-erbB-2 in primary breast cancer
about
The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patientsC-myc, not HER-2/neu, can predict recurrence and mortality of patients with node-negative breast cancerAmplification of fgfr4 gene in human breast and gynecological cancersHER2 testing: a review of detection methodologies and their clinical performanceMolecular biomarkers for breast cancer prognosis: coexpression of c-erbB-2 and p53Role of HER2 gene overexpression in breast carcinoma.Significance of the Fanconi anemia FANCD2 protein in sporadic and metastatic human breast cancerHER2: the neu prognostic marker for breast cancer.The epidermal growth factor receptor family in breast cancer.Testing for HER2 in Breast Cancer: A Continuing Evolution.Anti-human epidermal growth factor receptor 2 monoclonal antibody therapy for breast cancer.The significance of immunohistochemistry in the diagnosis and therapy of neoplasms.Predictive and prognostic markers for invasive breast cancer.Trastuzumab-associated cardiotoxicity.Image analysis and morphometry in the diagnosis of breast cancer.The role of HER-2 in Breast CancerStatistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.HER2 in solid tumors: more than 10 years under the microscope; where are we now?Retrospective analysis of metastatic behaviour of breast cancer subtypesClinical significance of erbB-2 (HER-2/neu) protein.The polymerase chain reaction: its use in the molecular characterization and diagnosis of cancers.IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.Prognostic significance of HER-2 status in women with inflammatory breast cancerTargeted therapy in breast cancer: the HER-2/neu gene and protein.Development of hyperplasias, preneoplasias, and mammary tumors in MMTV-c-erbB-2 and MMTV-TGFalpha transgenic rats.Prognostic significance of cathepsin-D in patients with breast cancerComparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease.c-erbB-2 positive breast tumours behave more aggressively in the first years after diagnosis.Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy.Personalized medicine in breast cancer: a systematic review.c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival.c-erbB-2 is not a major factor in the development of colorectal cancerExpression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma.RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancer.Paget's disease of the breast: the experience of the European Institute of Oncology and review of the literature.Recent perspectives of breast cancer prognosis and predictive factors.Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study.Targeting HER2 in Advanced Breast Cancer.HER2-positive early breast cancer and trastuzumab: a surgeon's perspective.
P2860
Q24644189-C7FB359B-ABAB-43EA-8864-435764AFF94EQ24795406-B12AD0A0-7F1E-4C70-8BA6-3976E3F8B61DQ28249028-BBAF1A52-449F-4B6E-BEC1-131F95EBE6AEQ28280488-28DB6389-0EEE-4A73-B942-C81ED4090912Q28363615-FE2E4771-8B37-47C3-B545-DFBA4BB9BE1BQ33810080-83884D4A-DD0B-4836-87F1-21A885204EFEQ33882536-84C9C56E-FFE0-4807-9437-4A0B4D9500ADQ34248406-B55BC9D1-7559-4D8A-ADC2-F8EBC29754E3Q34363400-061196A9-1471-4697-9BEF-F88CCF7642FDQ34424285-A9A09C33-61F2-4613-9EFE-BF09E2C39354Q34548277-7DDD35B7-0062-482D-8386-11C2D05C6889Q34602545-0FD731A2-59AB-4927-8283-34E199CBFDE9Q34612314-A2AE6355-A6E7-4791-BCF1-C4827F5CC49FQ34867708-4ED9F8E2-5DDC-4744-A1E2-6174A39ABBC3Q34954877-765068D3-E557-4722-8769-FB66AD675855Q35068343-06FDDF56-651D-40AB-A26B-5B764234A94BQ35168065-DD0E4179-EFDB-4528-A141-82D60460437DQ35211263-0B8E8037-9219-44DA-87ED-B22989D1D5C6Q35252752-1EA7F916-228B-465D-B085-56BC6B96EF1EQ35269163-EC74AD0C-A47B-4C1F-BE7C-74018CBA1CBBQ35367235-CB37C820-D2E8-4A1B-BE3A-EF1178EED1DFQ35588768-D37B93B8-9356-4311-AEA3-F91A74429FDFQ35624765-1B2B947A-ECEF-4B3A-8852-69A8538397D7Q35648508-C7905A54-B72C-484D-9D30-C821FE83B530Q35787289-2FFA6B21-5B83-448E-8081-621B30E73AC2Q35976409-F131E850-FE7D-4346-87D8-E68BCAC5A162Q35978203-C2700D09-5896-45AB-9206-2508EE1D0EC4Q35993223-E142D75D-9DD2-493C-9E65-1B4811475E06Q36080594-17F10587-A0C5-453E-9C7E-98F18329C43FQ36081269-B7AC5E62-5D9B-4854-8B1F-31E2D16C77A0Q36310182-4F3D0882-A962-450F-9FE1-E9BAF2DFE220Q36421775-382A251E-AB20-4F8B-97B9-83DC4FBD1D37Q36644043-22DD7EC4-F9E8-4DEA-823F-4E57ADFC2CF0Q36696088-533C21B4-30FB-4A6C-A4A2-3C85895555D2Q36718403-7EBD301B-0E6F-4C51-A132-D1D760962A7AQ37073633-9A1269CA-9DD3-4B54-AB4E-48CB405FE99DQ37407119-BBFCB514-D4C9-401E-9B7C-4581452678BDQ38484552-0FEECF77-A7A6-4479-B08F-2FDBC43083EFQ38632768-4CEE1E38-18F4-4476-921C-9D3402C6CCEAQ40105055-69A3FC36-E1C7-4191-A3E4-6619219B10EF
P2860
The long term prognostic significance of c-erbB-2 in primary breast cancer
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
The long term prognostic significance of c-erbB-2 in primary breast cancer
@ast
The long term prognostic significance of c-erbB-2 in primary breast cancer
@en
type
label
The long term prognostic significance of c-erbB-2 in primary breast cancer
@ast
The long term prognostic significance of c-erbB-2 in primary breast cancer
@en
prefLabel
The long term prognostic significance of c-erbB-2 in primary breast cancer
@ast
The long term prognostic significance of c-erbB-2 in primary breast cancer
@en
P2093
P2860
P356
P1476
The long term prognostic significance of c-erbB-2 in primary breast cancer
@en
P2093
Barraclough BR
Platt-Higgins A
Rudland PS
Spedding A
Winstanley J
P2860
P2888
P304
P356
10.1038/BJC.1991.103
P407
P577
1991-03-01T00:00:00Z